Drug Profile
Cytomegalovirus-glycoprotein vaccine (Pentamer) - Helocyte
Alternative Names: ConVax; gH/gL-PC vaccine - Helocyte; MVA-gH/gL-PC vaccine - Helocyte; Pentamer vaccineLatest Information Update: 28 Apr 2022
Price :
$50
*
At a glance
- Originator City of Hope National Medical Center
- Developer City of Hope National Medical Center; Helocyte
- Class Cytomegalovirus vaccines; Glycoproteins; Immunotherapies; Peptide vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cytomegalovirus infections
Most Recent Events
- 28 Apr 2022 No recent reports of development identified for preclinical development in Cytomegalovirus infections(Prevention) in USA (Parenteral, Injection)
- 25 Apr 2020 Cytomegalovirus-glycoprotein vaccine (pentamer) is still in preclinical development for Cytomegalovirus infections in USA (Parenteral, Injection)
- 28 Mar 2020 No recent reports of development identified for preclinical development in Cytomegalovirus infections (Prevention) in USA (Parenteral, Injection)